Transcenta Holding-B (06628) Receives First Installment Payment for Sale of CDMO Assets

Zhitong Finance APP News, Transcenta Holding Limited-B (06628) announces that, in relation to (among other things) the sale of CDMO assets to the purchaser (a wholly-owned subsidiary of WuXi Biologics) at a total consideration of RMB190 million. As of the date of this announcement, the Group has received from the purchaser the after-tax net amount of the first installment of the consideration, amounting to RMB95 million, in accordance with the terms of the asset purchase agreement. The proceeds received will be used to supplement the Group's general working capital and to develop the Group's product pipeline.